Case Control Study
Copyright ©The Author(s) 2022.
World J Gastroenterol. Jun 7, 2022; 28(21): 2320-2333
Published online Jun 7, 2022. doi: 10.3748/wjg.v28.i21.2320
Table 1 Participant characteristics and clinical parameters

HC (n = 26)
T2DM (n = 25)
T2DM + OSA (n =27)
P value
Sex, male/female17/917/821/60.584
Age, yr45.58 ± 8.8145.92 ± 13.8947.59 ± 5.180.728
BMI, kg/m224.63 ± 2.6125.84 ± 3.4527.03 ± 2.11b0.009
WHR, cm0.85 ± 0.060.95 ± 0.070.98 ± 0.05b< 0.001
NC, cm32.88 ± 3.7036.25 ± 4.7538.37 ± 2.31b< 0.001
FPG, mmol/L5.30 (4.70, 5.43)6.90 (6.30, 8.05)8.00 (6.40, 9.25)b< 0.001
HOMA-IR1.50 (1.09, 2.03)2.10 (1.02, 3.53)2.38 (1.37, 3.22)a0.099
HbA1c, %5.30 (5.10, 5.60)9.70 (7.30, 10.80)8.70 (7.70, 9.70)b< 0.001
SBP, mmHg117.50 (112.00, 123.25)130.00 (117.00, 143.00)131.00 (128.00, 144.00)b< 0.001
DBP, mmHg71.96 ± 5.4481.13 ± 11.3382.26 ± 8.58b< 0.001
HCY, μmol/L9.60 (8.30, 12.53)10.30 (8.05, 12.03)13.81 (10.73, 20.54)b,c< 0.001
AHI2.30 (1.48, 3.05)3.70 (2.00, 4.15)13.70 (9.80, 20.10)b,c< 0.001
Mean SpO2, %97.05 (96.50, 97.53)96.60 (96.05, 96.95)94.70 (93.80, 95.20)b,c< 0.001
Lowest SpO2, %85.50 (82.00, 90.25)85.00 (76.00, 87.50)81.00 (73.00, 84.00)b0.002
ODI0.65 (0.40, 1.23)2.20 (1.10, 5.45)9.10 (5.90, 15.30)b,c< 0.001